Trademarkia Logo

Australia

AU$
NURYLBO
Cancelled: Cancelled at the request of IB

Last updated on 22 Jan 2024

Owner Info

Ovid Therapeutics Inc.

1460 Broadway

New York NY 10036, UNITED STATES OF AMERICA

Serial Number

2096655 filed on 13 May 2020

Correspondent

Jeffrey S. Steen Carter, DeLuca & Farrell LLP

576 Broad Hollow Road,

Melville NY 11747,

UNITED STATES OF AMERICA

NURYLBO

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of developmental disorders; pharmaceutical preparations for the treatment of neurological disorders.

Mark Details


Serial Number

2096655

Registered On

13 May 2020

Renewal On

NA

Mark Type

WORD

Legal History


Show more

Status DateAction Taken
22nd Jan 2024Status change to Voided
22nd Dec 2020International Registration in Australia Protected correspondence sent
21st Dec 2020IP Right Registration Published
21st Dec 2020Status change to Registered/Protected
14th Oct 2020Application Accepted correspondence sent
14th Oct 2020IP Right has been Examined
14th Oct 2020IP Right Acceptance Published
2th Jul 2020Status change to Accepted
19th Jun 2020Awaiting examination
18th Jun 2020IP Right Filed Published